Zika virus—an update on the current efforts for vaccine development

References

• Dick SFK GWA, Haddow AJ. 1952. Zika virus (I). Isolations and serological specificity. Trans R Soc Trop Med Hyg. 46:509–20. doi:10.1016/0035-9203(52)90042-4.
   PubMed Web of Science ®Google Scholar
• Organization WH. 2017. Zika virus, microcephaly, Guillain-Barré syndrome.
   Google Scholar
• de Araujo TVB, Ximenes RAA, Miranda-Filho DB, Souza WV, Montarroyos UR, de Melo APL, Valongueiro S, de Albuquerque MFPM, Braga C, Filho SPB, et al. Association between microcephaly, Zika virus infection, and other risk factors in Brazil: final report of a case-control study. Lancet Infect Dis 2018;18:328–36.
   Google Scholar
• Styczynski AR, Malta J, Krow-Lucal ER, Percio J, Nobrega ME, Vargas A, Lanzieri TM, Leite PL, Staples JE, Fischer MX, et al. 2017. Increased rates of Guillain-Barre syndrome associated with Zika virus outbreak in the Salvador metropolitan area, Brazil. PLoS Negl Trop Dis. 11:e0005869. doi:10.1371/journal.pntd.0005869.
   PubMed Web of Science ®Google Scholar
• Jorritsma SHT, Gowans EJ, Grubor-Bauk B, Wijesundara DK. 2016. Delivery methods to increase cellular uptake and immunogenicity of DNA vaccines. Vaccine. 34:5488–94. doi:10.1016/j.vaccine.2016.09.062.
   PubMed Web of Science ®Google Scholar
• Larocca RA, Abbink P, Peron JP, Zanotto PM, Iampietro MJ, Badamchi-Zadeh A, Boyd M, Ng’ang’a D, Kirilova M, Nityanandam R, et al. 2016. Vaccine protection against Zika virus from Brazil. Nature. 536:474–78. doi:10.1038/nature18952.
   PubMed Web of Science ®Google Scholar
• Griffin BD, Muthumani K, Warner BM, Majer A, Hagan M, Audet J, Stein DR, Ranadheera C, Racine T, De La Vega M-A, et al. 2017. DNA vaccination protects mice against Zika virus-induced damage to the testes. Nat Commun. 8:15743. doi:10.1038/ncomms15743.
   PubMed Web of Science ®Google Scholar
• Abbink P, Larocca RA, De La Barrera RA, Bricault CA, Moseley ET, Boyd M, Kirilova M, Li Z, Nganga D, Nanayakkara O, et al. 2016. Protective efficacy of multiple vaccine platforms against Zika virus challenge in rhesus monkeys. Science. 353:1129–32. doi:10.1126/science.aah6157.
   PubMed Web of Science ®Google Scholar
• Muthumani K, Griffin BD, Agarwal S, Kudchodkar SB, Reuschel EL, Choi H, Kraynyak KA, Duperret EK, Keaton AA, Chung C, et al. 2016. In vivo protection against ZIKV infection and pathogenesis through passive antibody transfer and active immunisation with a prMEnv DNA vaccine. NPJ Vaccines. 1:16021. doi:10.1038/npjvaccines.2016.21.
   PubMed Web of Science ®Google Scholar
• Amaral MP, Apostolico JS, Tomita N, Coirada FC, Lunardelli VAS, Fernandes ER, Souza HFS, Astray RM, Boscardin SB, Rosa DS, et al. 2020. Homologous prime-boost with Zika virus envelope protein and poly (I:C) induces robust specific humoral and cellular immune responses. Vaccine. 38:3653–64. doi:10.1016/j.vaccine.2020.03.037.
   PubMed Web of Science ®Google Scholar
• Kutzler MA, Weiner DB. 2008. DNA vaccines: ready for prime time? Nat Rev Genet. 9:776–88. doi:10.1038/nrg2432.
   PubMed Web of Science ®Google Scholar
• Kardani K, Bolhassani A, Shahbazi S. 2016. Prime-boost vaccine strategy against viral infections: mechanisms and benefits. Vaccine. 34:413–23. doi:10.1016/j.vaccine.2015.11.062.
   PubMed Web of Science ®Google Scholar
• Tebas P, Roberts CC, Muthumani K, Reuschel EL, Kudchodkar SB, Zaidi FI, White S, Khan AS, Racine T, Choi H, et al. 2017. Safety and Immunogenicity of an Anti-Zika virus DNA vaccine - Preliminary report. N Engl J Med. doi:10.1056/NEJMoa1708120.
   Web of Science ®Google Scholar
• Gaudinski MR, Houser KV, Morabito KM, Hu Z, Yamshchikov G, Rothwell RS, Berkowitz N, Mendoza F, Saunders JG, Novik L, et al. 2018. Safety, tolerability, and immunogenicity of two Zika virus DNA vaccine candidates in healthy adults: randomised, open-label, phase 1 clinical trials. Lancet. 391:552–62. doi:10.1016/S0140-6736(17)33105-7.
   PubMed Web of Science ®Google Scholar
• Dowd KA, Ko SY, Morabito KM, Yang ES, Pelc RS, DeMaso CR, Castilho LR, Abbink P, Boyd M, Nityanandam R, et al. 2016. Rapid development of a DNA vaccine for Zika virus. Science. 354:237–40. doi:10.1126/science.aai9137.
   PubMed Web of Science ®Google Scholar
• Maciejewski S, Ruckwardt TJ, Morabito KM, Foreman BM, Burgomaster KE, Gordon DN, Pelc RS, DeMaso, CR, Ko SY, Fisher BE, et al. Distinct neutralizing antibody correlates of protection among related Zika virus vaccines identify a role for antibody quality. Sci Transl Med. 2020;12.
   Google Scholar
• Pardi N, Hogan MJ, Porter FW, Weissman D. 2018. mRNA vaccines - a new era in vaccinology. Nat Rev Drug Discov. 17:261–79. doi:10.1038/nrd.2017.243.
   PubMed Web of Science ®Google Scholar
• Pollard C, Rejman J, De Haes W, Verrier B, Van Gulck E, Naessens T, De Smedt S, Bogaert P, Grooten J, Vanham G, et al. 2013. Type I IFN counteracts the induction of antigen-specific immune responses by lipid- based delivery of mRNA vaccines. Mol Ther. 21:251–59. doi:10.1038/mt.2012.202.
   PubMed Web of Science ®Google Scholar
• Martinon F, Krishnan S, Lenzen G, Magne R, Gomard E, Guillet JG, Lévy J-P, Meulien P. 1993. Induction of virus-specific cytotoxic T lymphocytes in vivo by liposome-entrapped mRNA. Eur J Immunol. 23:1719–22. doi:10.1002/eji.1830230749.
   PubMed Web of Science ®Google Scholar
• Kranz LM, Diken M, Haas H, Kreiter S, Loquai C, Reuter KC, Meng M, Fritz D, Vascotto F, Hefesha H. 2016. Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy. Nature. 534:396–401. doi:10.1038/nature18300.
   PubMed Web of Science ®Google Scholar
• Pardi N, Hogan MJ, Pelc RS, Muramatsu H, Andersen H, DeMaso CR, Dowd KA, Sutherland LL, Scearce RM, Parks R, et al. 2017. Zika virus protection by a single low-dose nucleoside-modified mRNA vaccination. Nature. 543:248–51. doi:10.1038/nature21428.
   PubMed Web of Science ®Google Scholar
• Richner JM, Himansu S, Dowd KA, Butler SL, Salazar V, Fox JM, Julander JG, Tang WW, Shresta S, Pierson TC, et al. 2017. Modified mRNA vaccines protect against Zika virus infection. Cell. 168:1114–25 e10. doi:10.1016/j.cell.2017.02.017.
   PubMed Web of Science ®Google Scholar
• Jagger BW, Dowd KA, Chen RE, Desai P, Foreman B, Burgomaster KE, Himansu S, Kong W-P, Graham BS, Pierson TC, et al. 2019. Protective efficacy of nucleic acid vaccines against transmission of Zika virus during pregnancy in mice. J Infect Dis. 220:1577–88. doi:10.1093/infdis/jiz338.
   PubMed Web of Science ®Google Scholar
• Abbink P, Larocca RA, Visitsunthorn K, Boyd M, De La Barrera RA, Gromowski GD, Kirilova M, Peterson R, Li Z, Nanayakkara O, et al. 2017. Durability and correlates of vaccine protection against Zika virus in rhesus monkeys. Sci Transl Med. 9:eaao4163. doi:10.1126/scitranslmed.aao4163.
   PubMed Web of Science ®Google Scholar
• Lecouturier V, Bernard MC, Berry C, Carayol S, Richier E, Boudet F, Heinrichs J. 2019. Immunogenicity and protection conferred by an optimized purified inactivated Zika vaccine in mice. Vaccine. 37:2679–86. doi:10.1016/j.vaccine.2019.04.013.
   PubMed Web of Science ®Google Scholar
• Baldwin WR, Livengood JA, Giebler HA, Stovall JL, Boroughs KL, Sonnberg S, Bohning KJ, Dietrich EA, Ong YT, Danh HK. 2018. Purified inactivated Zika vaccine candidates afford protection against lethal challenge in mice. Sci Rep. 8:16509. doi:10.1038/s41598-018-34735-7.
   PubMed Web of Science ®Google Scholar
• Sumathy K, Kulkarni B, Gondu RK, Ponnuru SK, Bonguram N, Eligeti R, Gadiyaram S, Praturi U, Chougule B, Karunakaran L, et al. 2017. Protective efficacy of Zika vaccine in AG129 mouse model. Sci Rep. 7:46375. doi:10.1038/srep46375.
   PubMed Web of Science ®Google Scholar
• Ng WC, Soto-Acosta R, Bradrick SS, Garcia-Blanco MA, Ooi EE. 2017. The 5ʹ and 3ʹ untranslated regions of the flaviviral genome. Viruses. 9:137. doi:10.3390/v9060137.
   PubMed Web of Science ®Google Scholar
• Shan C, Muruato AE, Jagger BW, Richner J, Nunes BTD, Medeiros DBA, Xie X, Nunes JGC, Morabito KM, Kong W-P, et al. 2017. A single-dose live-attenuated vaccine prevents Zika virus pregnancy transmission and testis damage. Nat Commun. 8:676. doi:10.1038/s41467-017-00737-8.
   PubMed Web of Science ®Google Scholar
• Zou J, Xie X, Luo H, Shan C, Muruato AE, Weaver SC, Wang T, Shi P-Y. 2018. A single-dose plasmid-launched live-attenuated Zika vaccine induces protective immunity. EBioMedicine. 36:92–102. doi:10.1016/j.ebiom.2018.08.056.
   PubMed Web of Science ®Google Scholar
• Xie X, Yang Y, Muruato AE, Zou J, Shan C, Nunes BT, Medeiros DBA, Vasconcelos PFC, Weaver SC, Rossi SL. 2017. Understanding Zika virus stability and developing a chimeric vaccine through functional analysis. mBio. 8(1). doi:10.1128/mBio.02134-16.
   PubMed Web of Science ®Google Scholar
• Cox F, van der Fits L, Abbink P, Larocca RA, van Huizen E, Saeland E, Verhagen J, Peterson R, Tolboom J, Kaufmann B, et al. 2018. Adenoviral vector type 26 encoding Zika virus (ZIKV) M-Env antigen induces humoral and cellular immune responses and protects mice and nonhuman primates against ZIKV challenge. PLoS One. 13(8):e0202820. doi:10.1371/journal.pone.0202820.
   PubMed Web of Science ®Google Scholar
• Guo Q, Chan JF, Poon VK, Wu S, Chan CC, Hou L, Yip CCY, Ren C, Cai J-P, Zhao M, et al. 2018. Immunization with a novel human type 5 adenovirus-vectored vaccine expressing the premembrane and envelope proteins of Zika virus provides consistent and sterilizing protection in multiple immunocompetent and immunocompromised animal models. J Infect Dis. 218(3):365–77. doi:10.1093/infdis/jiy187.
   PubMed Web of Science ®Google Scholar
• Lopez-Camacho C, Abbink P, Larocca RA, Dejnirattisai W, Boyd M, Badamchi-Zadeh A, Wallace ZR, Doig J, Velazquez RS, Neto RDL, et al. Rational Zika vaccine design via the modulation of antigen membrane anchors in chimpanzee adenoviral vectors. Nat Commun. 2018;9:2441. doi:10.1038/s41467-018-04859-5
   Google Scholar
• Prow NA, Liu L, Nakayama E, Cooper TH, Yan K, Eldi P, Hazlewood JE, Tang B, Le TT, Setoh YX, et al. 2018. A vaccinia- based single vector construct multi-pathogen vaccine protects against both Zika and chikungunya viruses. Nat Commun. 9:1230. doi:10.1038/s41467-018-03662-6.
   PubMed Web of Science ®Google Scholar
• Xu K, Song Y, Dai L, Zhang Y, Lu X, Xie Y, Zhang H, Cheng T, Wang Q, Huang Q, et al. Recombinant Chimpanzee Adenovirus Vaccine AdC7-M/E Protects against Zika Virus Infection and Testis Damage. J Virol. 2018;92..
   Google Scholar
• Emanuel J, Callison J, Dowd KA, Pierson TC, Feldmann H, Marzi A. 2018. A VSV- based Zika virus vaccine protects mice from lethal challenge. Sci Rep. 8:11043. doi:10.1038/s41598-018-29401-x.
   PubMed Web of Science ®Google Scholar
• Nurnberger C, Bodmer BS, Fiedler AH, Gabriel G, Muhlebach MD. A measles virus-based vaccine candidate mediates protection against Zika virus in an allogeneic mouse pregnancy model. J Virol. 2019;93.
   Web of Science ®Google Scholar